Multicentric and Retrospective Analysis of Adolescent Young Adult (AYA) Hodgkins' Lymphoma Patients
NCT05663983 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 600
Last updated 2022-12-23
Summary
The principal aim of this study is to collect retrospectively all Adolescent Young Adult patients affected by Hodgkin's Lymphoma and treated in pediatric or adult haemato-oncology Centers. The data set collection aims to define the therapy performed and the results obtained in terms of overall survival and acute or late complications.
Conditions
- Hodgkin Lymphoma
- Adolescent Behavior
- Chemotherapy Effect
Interventions
- BEHAVIORAL
-
Description of therapeutical results
Comparison between two groups of patients treated in different realities (Pediatric Hospital or Adult General Hospital)
Sponsors & Collaborators
-
Associazione Italiana di Ematologia e Oncologia Pediatrica
collaborator UNKNOWN -
Fondazione Italiana Linfomi
collaborator UNKNOWN -
Campus Bio-Medico University
lead OTHER
Eligibility
- Min Age
- 15 Years
- Max Age
- 24 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-01-31
- Primary Completion
- 2023-12-31
- Completion
- 2024-12-31
More Related Trials
-
Study on Plasmablastic Lymphoma Patients
NCT06781359 ·Status: RECRUITING
-
Quality Of Life On Elderly Patients With Low Grade Non-Hodgkin Lymphoma
NCT05524298 ·Status: RECRUITING
-
Auto/Allo Tandem Transplant for Relapsed B-NHL
NCT03205657 ·Status: COMPLETED
-
Dose Dense Chemotherapy + Rituximab +/-Intensified High Dose Chemoimmunotherapy With Support of Peripheral Autologous Stem Cell in Diffuse Large B-Cell Lymphoma
NCT00499018 ·Status: UNKNOWN ·Phase: PHASE3
-
Efficacy of a Treatment With CHOP and Lenalidomide in First Line in Angioimmunoblastic T-cell Lymphoma (AITL)
NCT01553786 ·Status: COMPLETED ·Phase: PHASE2
-
Correlation Analysis of T-lymphocyte Subsets and Prognosis in Autologous Stem Cell Transplantation (ASCT) for Lymphoma
NCT03283111 ·Status: UNKNOWN ·Phase: NA
-
A Prospective, Observational Cohort Study on the Clinical Impact of Novel Monoclonal Antibodies in B-cell Non-Hodgkin Lymphoma in Italian Clinical Practice
NCT06008691 ·Status: RECRUITING
-
Efficacy and Safety of Oral Azacitidine (CC-486) Compared to Investigator's Choice Therapy in Patients With Relapsed or Refractory Angioimmunoblastic T Cell Lymphoma
NCT03703375 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Allo-HSCT vs ASCT in Adult T-LBL
NCT06741813 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Immunotherapy in Peripheral T Cell Lymphoma - the Role of Alemtuzumab in Addition to Dose Dense CHOP
NCT00725231 ·Status: UNKNOWN ·Phase: PHASE3
-
Lenalidomide Maintenance Post-debulking in Advanced CTCL
NCT01098656 ·Status: TERMINATED ·Phase: PHASE3
-
Chemotherapy Plus Rituximab Combination for Adult Lymphoblastic Leukemia (B-ALL) and Burkitt's Non-Hodgkin Lymphoma
NCT01290120 ·Status: COMPLETED ·Phase: PHASE2
-
Intergroup Randomized Trial for Children or Adolescents With B-Cell Non Hodgkin Lymphoma or B-Acute Leukemia: Rituximab Evaluation in High Risk Patients
NCT01516580 ·Status: COMPLETED ·Phase: PHASE3
-
A Prospective Multicenters Clinical Cohort Study of Stratified Treatment of Chinese Children With LBL
NCT03971318 ·Status: UNKNOWN
-
Intensive Chemo-immunotherapy as First Line Treatment in Adult Patients With Peripheral T- Cell Lymphoma
NCT01679860 ·Status: COMPLETED ·Phase: PHASE2
-
Italian Study of Patients With Lymphoma
NCT06814925 ·Status: RECRUITING
-
Identification of New Immune Factors Specific of Relapse in Childhood B Lineage Acute Lymphoblastic Leukemia
NCT02618109 ·Status: TERMINATED ·Phase: PHASE4
-
Study for Elderly (≥ 65 Years) Patients With Classical Hodgkin Lymphoma Undergoing CGA at Diagnosis
NCT03552003 ·Status: RECRUITING
-
Kinetic of Cytokines Decrease and Hodgkin Lymphoma Prognostic
NCT01833884 ·Status: COMPLETED ·Phase: NA
-
Study of Epigenetic and Inflammatory Markers of Accelerated Biological Ageing in the Follow up of Patients With Hodgkin's Lymphoma
NCT06761274 ·Status: RECRUITING ·Phase: NA
-
Rituximab in Treating Young Patients Who Are Receiving Chemotherapy for B-Cell Non-Hodgkin's Lymphoma or B-Cell Acute Lymphoblastic Leukemia
NCT00324779 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Brentuximab Vedotin in Adults With Hodgkin's Lymphoma
NCT05100056 ·Status: RECRUITING
-
Phase III, Randomized Trial: Lenalidomide vs Observation After Induction With Rituximab Followed by Cht and ASCT in MCL Adult Patients
NCT02354313 ·Status: UNKNOWN ·Phase: PHASE3
-
Comparison of HD Chemotherapy Followed by Auto-transplant and R-CHOP in High Risk Patients With DLBCL.
NCT00355199 ·Status: COMPLETED ·Phase: PHASE3
-
Systemic Therapies in the Treatment of Cutaneous T-cell Lymphoma
NCT06588868 ·Status: RECRUITING